Sapient Capital LLC Merck & Co., Inc. Transaction History
Sapient Capital LLC
- $5.49 Billion
- Q2 2025
A detailed history of Sapient Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 11,782 shares of MRK stock, worth $950,689. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,782
Previous 329,792
96.43%
Holding current value
$950,689
Previous $29.6 Million
96.85%
% of portfolio
0.02%
Previous 0.59%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,858Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.73 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.59 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.76 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $204B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...